Therapies and Procedures

Therapies and Procedures

Degenerative mitral valve regurgitation is the third most common cardiovascular disease in both the US and Europe. These patients, if left untreated until symptoms are severe, 35% die from complications resulting from increased morbidity associated with mitral regurgitation (MR).

NeoChord offers a surgical beating heart option for treating mitral valve disease. We are focused on improving the lives of patients and developing innovative technologies that lead to products designed for ease of use and serve the unmet needs of patients around the world.